Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Other Non-Current Assets (2019 - 2025)

Pliant Therapeutics (PLRX) has disclosed Other Non-Current Assets for 7 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 240.69% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 240.69% year-over-year, with the annual reading at $1.5 million for FY2025, 240.69% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $1.5 million at Pliant Therapeutics, roughly flat from $1.5 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $1.5 million in Q1 2024, with the low at $391000.0 in Q2 2025.
  • Average Other Non-Current Assets over 5 years is $944466.7, with a median of $835000.0 recorded in 2022.
  • Peak annual rise in Other Non-Current Assets hit 240.69% in 2025, while the deepest fall reached 73.62% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $831000.0 in 2021, then crashed by 52.23% to $397000.0 in 2022, then decreased by 1.26% to $392000.0 in 2023, then rose by 10.97% to $435000.0 in 2024, then soared by 240.69% to $1.5 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $1.5 million, $1.5 million, and $391000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.